Martin Olivo's Colleagues at Protara Therapeutics
Justine OMalley
Vice President, Investor Relations and Corporate Communications Protara Therapeutics
Jaymie Berger
R&D Team Administrator, Executive Assistant to Chief Scientific Operations Officer
Martin Olivo's Contact Details
N/A
New York, New York, United States
Protara Therapeutics
Martin Olivo's Company Details
Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. Protara's portfolio includes its lead program, TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational, intravenous phospholipid substrate replacement therapy in development for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.